ADMA Biologics Inc (NASDAQ:ADMA)

Delayed Data
As of Feb 23
 +0.01 / +0.27%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for ADMA Biologics Inc have a median target of 8.00, with a high estimate of 15.00 and a low estimate of 5.00. The median estimate represents a +111.64% increase from the last price of 3.78.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in ADMA Biologics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 54.80%
Growthannually -15.22%


Growthquarterly 34.26%
Growthannually 63.73%
Key to the earnings and sales forecast charts.